| William E Perez, MD | |
|
4500 Parsons Blvd, Flushing, NY 11355-2205 | |
| (718) 670-5631 | |
| (718) 670-4446 |
| Full Name | William E Perez |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 42 Years |
| Location | 4500 Parsons Blvd, Flushing, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063455590 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 177648 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Day Medical Pc | 8022338946 | 10 |
News Archive
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
There is growing evidence that pregnant women who go beyond term, especially first time mothers and their infants, will benefit from induction of labour at 41 weeks, instead of expectant management with subsequent induction of labour at 42 weeks if labour will not start spontaneously.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
Illumina, Inc. today introduced Nextera Exome and Custom Enrichment kits, the Company's latest targeted resequencing solutions offering sample preparation and enrichment in a single, integrated workflow.
Jesse Stewart, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, and two colleagues have received a $2.2 million National Institutes of Health grant to investigate the links between depression, depression treatment and cardiovascular disease in adults with HIV.
› Verified 4 days ago
| Entity Name | Comprehensive Anesthesia Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255386231 PECOS PAC ID: 9537072798 Enrollment ID: O20031112000598 |
News Archive
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
There is growing evidence that pregnant women who go beyond term, especially first time mothers and their infants, will benefit from induction of labour at 41 weeks, instead of expectant management with subsequent induction of labour at 42 weeks if labour will not start spontaneously.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
Illumina, Inc. today introduced Nextera Exome and Custom Enrichment kits, the Company's latest targeted resequencing solutions offering sample preparation and enrichment in a single, integrated workflow.
Jesse Stewart, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, and two colleagues have received a $2.2 million National Institutes of Health grant to investigate the links between depression, depression treatment and cardiovascular disease in adults with HIV.
› Verified 4 days ago
| Entity Name | New Day Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396131272 PECOS PAC ID: 8022338946 Enrollment ID: O20150517000000 |
News Archive
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
There is growing evidence that pregnant women who go beyond term, especially first time mothers and their infants, will benefit from induction of labour at 41 weeks, instead of expectant management with subsequent induction of labour at 42 weeks if labour will not start spontaneously.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
Illumina, Inc. today introduced Nextera Exome and Custom Enrichment kits, the Company's latest targeted resequencing solutions offering sample preparation and enrichment in a single, integrated workflow.
Jesse Stewart, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, and two colleagues have received a $2.2 million National Institutes of Health grant to investigate the links between depression, depression treatment and cardiovascular disease in adults with HIV.
› Verified 4 days ago
| Entity Name | Nhpe Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1134665193 PECOS PAC ID: 8325325343 Enrollment ID: O20170501000649 |
News Archive
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
There is growing evidence that pregnant women who go beyond term, especially first time mothers and their infants, will benefit from induction of labour at 41 weeks, instead of expectant management with subsequent induction of labour at 42 weeks if labour will not start spontaneously.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
Illumina, Inc. today introduced Nextera Exome and Custom Enrichment kits, the Company's latest targeted resequencing solutions offering sample preparation and enrichment in a single, integrated workflow.
Jesse Stewart, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, and two colleagues have received a $2.2 million National Institutes of Health grant to investigate the links between depression, depression treatment and cardiovascular disease in adults with HIV.
› Verified 4 days ago
| Entity Name | Star Suites Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1023588266 PECOS PAC ID: 7315284551 Enrollment ID: O20190128000196 |
News Archive
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
There is growing evidence that pregnant women who go beyond term, especially first time mothers and their infants, will benefit from induction of labour at 41 weeks, instead of expectant management with subsequent induction of labour at 42 weeks if labour will not start spontaneously.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
Illumina, Inc. today introduced Nextera Exome and Custom Enrichment kits, the Company's latest targeted resequencing solutions offering sample preparation and enrichment in a single, integrated workflow.
Jesse Stewart, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, and two colleagues have received a $2.2 million National Institutes of Health grant to investigate the links between depression, depression treatment and cardiovascular disease in adults with HIV.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William E Perez, MD Po Box 270, Massapequa Park, NY 11762-0270 Ph: (631) 264-2035 | William E Perez, MD 4500 Parsons Blvd, Flushing, NY 11355-2205 Ph: (718) 670-5631 |
News Archive
"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.
There is growing evidence that pregnant women who go beyond term, especially first time mothers and their infants, will benefit from induction of labour at 41 weeks, instead of expectant management with subsequent induction of labour at 42 weeks if labour will not start spontaneously.
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.
Illumina, Inc. today introduced Nextera Exome and Custom Enrichment kits, the Company's latest targeted resequencing solutions offering sample preparation and enrichment in a single, integrated workflow.
Jesse Stewart, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, and two colleagues have received a $2.2 million National Institutes of Health grant to investigate the links between depression, depression treatment and cardiovascular disease in adults with HIV.
› Verified 4 days ago
Dr. Oscar Roldan, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 14030 Beech Ave Apt 4t, Flushing, NY 11355 Phone: 407-506-6751 | |
Deemah Stalhamer, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4500 Parsons Blvd, Flushing, NY 11355 Phone: 718-670-5631 Fax: 718-670-4446 | |
Adam Hom, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 10201 66th Rd, Flushing, NY 11375 Phone: 917-837-2030 | |
Michelle Evans, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4500 Parsons Blvd, Flushing, NY 11355 Phone: 718-670-5631 Fax: 718-670-4446 | |
Dr. Usha Krishnamurthy, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5516 Main St, Suite 1b, Flushing, NY 11355 Phone: 718-461-0017 Fax: 718-461-0018 | |
Rafaelita B Samala, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3609 Main St, Suite 201, Flushing, NY 11354 Phone: 718-321-7558 |